ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Text of concept statement included in this 8-page issue.

July 16, 2004

Niederhuber Outlines NCI Grant Funding Policies for FY08.

February 8, 2008

Harvest Yet To Come From Radiotherapy Advances, Kaplan Tells NCAB

October 17, 1975

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

June 14, 2013

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007